SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Alteryx, Inc. – ‘S-8’ on 8/3/22 – ‘EX-5.1’

On:  Wednesday, 8/3/22, at 4:07pm ET   ·   Effective:  8/3/22   ·   Accession #:  1193125-22-211264   ·   File #:  333-266489

Previous ‘S-8’:  ‘S-8’ on 2/15/22   ·   Next:  ‘S-8’ on 2/10/23   ·   Latest:  ‘S-8’ on 2/6/24   ·   25 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/03/22  Alteryx, Inc.                     S-8         8/03/22    4:79K                                    Donnelley … Solutions/FA

Registration Statement – Securities for an Employee Benefit Plan   —   Form S-8   —   SA’33

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-8         Registration Statement - Securities for an          HTML     49K 
                Employee Benefit Plan                                            
 2: EX-5.1      Opinion of Counsel re: Legality                     HTML     12K 
 3: EX-23.1     Consent of Expert or Counsel                        HTML      5K 
 4: EX-FILING FEES  Filing Fees                                     HTML     13K 


‘EX-5.1’   —   Opinion of Counsel re: Legality


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  EX-5.1  

Exhibit 5.1

 

LOGO   

555 California Street

12th Floor

San FranciscoCA 94104

  

415.875.2300

Fenwick.com

August 3, 2022

Alteryx, Inc.

17200 Laguna Canyon Road

Irvine, California 92618

Ladies and Gentlemen:

At your request, as your counsel, we have examined the Registration Statement on Form S-8 (the “Registration Statement”) to be filed by Alteryx, Inc., a Delaware corporation (the “Company”), with the Securities and Exchange Commission (the “Commission”) on or about, August 3, 2022 in connection with the registration under the Securities Act of 1933, as amended (the “Securities Act”), of the issuance of an aggregate of 6,100,000 shares (the “Shares”) of the Company’s Class A Common Stock, $0.0001 par value per share (the “Class A Common Stock”), subject to issuance by the Company upon the exercise or settlement of awards granted or to be granted under the Company’s Amended and Restated 2017 Equity Incentive Plan, as amended to date (the “Restated 2017 Plan”).

At your request we are providing this letter to express our opinion on the matters set forth below in this letter (“our opinion”).

In connection with our opinion, we have examined such matters of fact as we have deemed necessary, which included examination of originals or copies of: the Company’s current Restated Certificate of Incorporation and Amended and Restated Bylaws, as amended (collectively, the “Charter Documents”), the Registration Statement and the exhibits thereto, the prospectuses relating to the Restated 2017 Plan, certain corporate proceedings of the Company’s Board of Directors (the “Board”) and the Company’s stockholders relating to adoption or approval of the Charter Documents, the Restated 2017 Plan and related forms of Restated 2017 Plan agreements for use thereunder, the reservation of the Shares for sale and issuance, the filing of the Registration Statement and the registration of the issuance of the Shares under the Securities Act, and documents (including a certificate from the Company’s transfer agent) regarding the Company’s outstanding and reserved capital stock and other securities and such other documents as we have deemed advisable, and we have examined such questions of law as we have considered necessary.

In our examination of documents for purposes of this opinion, we have assumed, and express no opinion as to, the authenticity and completeness of all documents submitted to us as originals, the genuineness of signatures on documents reviewed by us, the conformity to originals and the completeness of all documents submitted to us as copies, the legal capacity of all parties executing any documents (other than the Company), the lack of any undisclosed termination or modification or waiver of any document, the absence of any extrinsic agreements or documents that might change or affect the interpretation or terms of documents, and the due authorization, execution and delivery of all documents by each party thereto other than the Company. We have also assumed that any certificates or instruments representing the Shares, if and when issued, will be executed by the Company by officers of the Company duly authorized to do so. In rendering our opinion, we have also relied upon a Certificate of Good Standing dated August 3, 2022 issued by the Delaware Secretary of State with respect to the Company and representations and certifications made to us by the Company, including without limitation representations in a Management Certificate addressed to us of even date herewith, that the Company has available a sufficient number of authorized shares of Class A Common Stock that are not currently outstanding or reserved for issuance under other outstanding securities or plans of the Company, to enable the Company to issue and deliver all of the Shares as of the date of this letter.


We render this opinion only with respect to, and we express no opinion herein concerning the application or effect of the laws of any jurisdiction other than, the existing Delaware General Corporation Law now in effect. We express no opinion with respect to the securities or “blue sky” laws of any state.

Based upon, and subject to, the foregoing, it is our opinion that when the 6,100,000 Shares of Class A Common Stock that may be issued and sold by the Company upon the exercise or settlement of awards granted or to be granted under the Restated 2017 Plan, have been issued and sold by the Company against the Company’s receipt of payment therefor (in an amount and type of consideration not less than the par value per Share) in accordance with the terms (including without limitation payment and authorization provisions) of the Restated 2017 Plan and have been duly registered on the books of the transfer agent and registrar for the Shares in the name or on behalf of the holders thereof, such Shares will be validly issued, fully paid and non-assessable.

We consent to the use of this opinion as an exhibit to the Registration Statement and further consent to all references to us, if any, in the Registration Statement, the prospectuses constituting a part thereof and any amendments thereto. We do not thereby admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission thereunder. This opinion is intended solely for use in connection with issuance and sale of the Shares subject to the Registration Statement and is not to be relied upon for any other purpose. In providing this letter, we are opining only as to the specific legal issues expressly set forth above, and no opinion shall be inferred as to any other matter or matters. This opinion is rendered on, and speaks only as of, the date of this letter first written above, and does not address any potential change in facts or law that may occur after the date of this opinion letter. We assume no obligation to advise you of any fact, circumstance, event or change in the law or the facts that may hereafter be brought to our attention, whether or not such occurrence would affect or modify any of the opinions expressed herein.

 

Very truly yours,

/s/ Fenwick & West LLP

FENWICK & WEST LLP


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘S-8’ Filing    Date    Other Filings
Filed on / Effective on:8/3/2210-Q
 List all Filings 


11 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/19/24  Alteryx, Inc.                     S-8 POS     3/19/24    1:30K                                    Donnelley … Solutions/FA
 3/19/24  Alteryx, Inc.                     S-8 POS     3/19/24    1:30K                                    Donnelley … Solutions/FA
 3/19/24  Alteryx, Inc.                     S-8 POS     3/19/24    1:30K                                    Donnelley … Solutions/FA
 3/19/24  Alteryx, Inc.                     S-8 POS     3/19/24    1:30K                                    Donnelley … Solutions/FA
 3/19/24  Alteryx, Inc.                     S-8 POS     3/19/24    1:30K                                    Donnelley … Solutions/FA
 3/19/24  Alteryx, Inc.                     S-8 POS     3/19/24    1:30K                                    Donnelley … Solutions/FA
 3/19/24  Alteryx, Inc.                     S-8 POS     3/19/24    1:30K                                    Donnelley … Solutions/FA
 3/19/24  Alteryx, Inc.                     S-8 POS     3/19/24    1:30K                                    Donnelley … Solutions/FA
 3/19/24  Alteryx, Inc.                     S-8 POS     3/19/24    1:30K                                    Donnelley … Solutions/FA
 2/06/24  Alteryx, Inc.                     S-8         2/06/24    4:101K                                   Broadridge Fin’l So… Inc
 2/10/23  Alteryx, Inc.                     S-8         2/10/23    4:111K                                   Broadridge Fin’l So… Inc


14 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/03/22  Alteryx, Inc.                     10-Q        6/30/22   77:8.4M
 5/27/22  Alteryx, Inc.                     8-K:5,9     5/25/22   12:440K
 5/04/22  Alteryx, Inc.                     10-Q        3/31/22   80:9.1M
 3/16/22  Alteryx, Inc.                     8-K:5       3/10/22   10:158K                                   Donnelley … Solutions/FA
 2/15/22  Alteryx, Inc.                     10-K       12/31/21  109:12M
 2/08/22  Alteryx, Inc.                     8-K:2,9     2/07/22   11:157K                                   Donnelley … Solutions/FA
 2/03/22  Alteryx, Inc.                     8-K:5       1/31/22   11:193K
 1/10/22  Alteryx, Inc.                     8-K:5       1/05/22   11:192K
 1/07/22  Alteryx, Inc.                     8-K:1,2,9   1/06/22   12:5.9M                                   Donnelley … Solutions/FA
 5/05/20  Alteryx, Inc.                     8-K:5,9     5/05/20   13:394K
 5/11/17  Alteryx, Inc.                     10-Q        3/31/17   58:3.5M                                   Donnelley … Solutions/FA
 3/16/17  Alteryx, Inc.                     8-A12B                 1:18K                                    Donnelley … Solutions/FA
 3/13/17  Alteryx, Inc.                     S-1/A                  6:3.7M                                   Donnelley … Solutions/FA
 2/24/17  Alteryx, Inc.                     S-1                   20:7.6M                                   Donnelley … Solutions/FA
Top
Filing Submission 0001193125-22-211264   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 12:26:47.1pm ET